Vivek G Patel, MD, is an assistant professor of medicine in the Division of Hematology Oncology at Vanderbilt University Medical Center.
Vivek G. Patel, MD, discusses the potential advantages of subcutaneous bispecific antibodies that are being evaluated in frontline follicular lymphoma.
Vivek G. Patel, MD, discusses the safety profile of bispecific antibodies for the treatment of patients with follicular lymphoma.
Vivek G Patel, MD, discusses the comparative efficacy and safety profiles of mosunetuzumab and epcoritamab in follicular lymphoma.
Published: May 2nd 2025 | Updated: May 2nd 2025
